Schizophrenia

Did you know that schizophrenia affects more than 1 percent of the world's population?

See NARSAD Grants at work on the latest schizophrenia research

Schizophrenia is a severe, chronic, and generally disabling brain and behavior disorder. It is most accurately described as a psychosis - a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behavior. Schizophrenia is believed to be caused by a combination of genetic and environmental factors.

Positive symptoms may include delusions, thought disorders, and hallucinations. People with schizophrenia may hear voices other people don't hear, or believe other people are reading their minds, controlling their thoughts, or plotting to harm them. Negative symptoms may include avolition (a lack of desire or motivation to accomplish goals), lack of desire to form social relationships, and blunted affect and emotion. Cognitive symptoms involve problems with attention and memory, especially in planning and organization to achieve a goal. Cognitive deficits are the most disabling for patients trying to lead a normal life.

learn more about schizophrenia

Visit the Schizophrenia Research Forum, fully sponsored by the Brain & Behavior Research Foundation—a virtual community of scientists collaborating in their quest for causes, improved treatments, and better understanding of schizophrenia.

Visit the Schizophrenia Research Forum for more information about research

 

NARSAD Grantee, Aristotle Voineskos, M.D., Ph.D., FRCP(C) from the Centre for Addiction and Mental Health (CAMH), Expert on Schizophrenia
Dr. Aristotle Voineskos
March 06, 2013
In a new imaging-genetics study, NARSAD Grantees have uncovered a single gene that may explain dramatic differences among people with schizophrenia. The study...
Tiffany Herlands, Psy.D.
Tiffany Herlands, Psy.D.
March 01, 2013
WOMEN’S MENTAL HEALTH CONFERENCE: THE ART & SCIENCE OF CARING From The Quarterly, Winter 2013 On September 14, 2012 the Brain & Behavior Research...
Debra Titone, Ph.D. at McGill University, Expert on schizophrenia and schizophrenia warning signs
Debra Titone, Ph.D.
February 25, 2013
A recent study, led in part by NARSAD Young Investigator Grantee Debra Titone, Ph.D. at McGill University, indicates that patients with schizophrenia are...
Christopher R. Bowie, Ph.D., C.Psych., Director, Cognitive and Psychotic Disorders Laboratory and Associate Professor, Departments of Psychology & Psychiatry, Queen's University, Kingston, ON, Canada, Expert on Schizophrenia
Dr. Christopher Bowie
February 19, 2013
Dr. Christopher Bowie used his 2007 NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation to conduct a study that shows how...
NARSAD Grantee Tsuyoshi Miyakawa, Ph.D., , expert on schizophrenia, at the Institute for Comprehensive Medical Science, Fujita Health University and the National Institute for Physiological Sciences, Japan
Tsuyoshi Miyakawa, Ph.D.
February 12, 2013
Researchers have discovered a protein deficiency that results in mild chronic brain inflammation and is thought to lead to schizophrenia-related symptoms, such...

Pages

Subscribe to